Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 68788-7793

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 68788-7793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion 200mg 1000tab

This is a description of medication called Bupropion HCI Extended-Release tablets SR 200mg, which is a generic version of Wellbutria SR. Each extended-release tablet contains 200mg of the active ingredient Bupropion HCL USP. This medication was manufactured by ScieGen Pharmaceuticals, Inc. with a specific lot number, batch number, and expiration date. The text mentions instructions in Spanish for taking the tablet but does not provide any further information. Additionally, there is a warning not to transfer the drug to anyone other than the person for whom it was prescribed, as it is prohibited by federal law.*

FDA Label Image

Chemical Structure (Bupropion Hydrochloride Sr 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.